Institutional Ownership
Neuropace Inc
CUSIP 641288105COMNPCEQ1 2026
13D / 13G Filings
31
Schedule 13D/13G on record
Beneficial Filers
11
Distinct reporting persons
Largest Stake
23.0%
Max % of class reported
Institutional Holders
108
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
31 filings · latest Nov 7, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 7, 2025 | Soleus Private Equity Fund I, L.P. | 13G/A | 8.9% | 2.96M | SEC |
| 2 | Sep 3, 2025 | Kck Ltd. | 13G/A | — | — | SEC |
| 3 | Aug 14, 2025 | Orbimed Advisors LLC | 13G/A | 8.0% | 26.14T | SEC |
| 4 | Aug 5, 2025 | Soleus Private Equity Fund I, L.P. | 13G/A | 7.0% | 2.30M | SEC |
| 5 | May 15, 2025 | Polar Capital Holdings PLC | 13G | 9.1% | 2.97M | SEC |
| 6 | May 15, 2025 | Orbimed Advisors LLC | 13G/A | 10.5% | 34.06T | SEC |
| 7 | Feb 14, 2025 | Kent Lake Pr LLC | 13G/A | 4.9% | — | SEC |
| 8 | Feb 11, 2025 | Kck Ltd. | 13G/A | 17.7% | 5.27M | SEC |
| 9 | Feb 4, 2025 | Morgan Stanley | 13G/A | 8.3% | 2.49M | SEC |
| 10 | Nov 14, 2024 | Soleus Private Equity Fund I, L.P. | 13G/A | 2.0% | 582.2K | SEC |
21 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Neuropace Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Polar Capital Holdings PLC | 3.30M | $43.37M |
| 2 | Soleus Capital Management, L.P. | 2.93M | $38.56M |
| 3 | Morgan Stanley | 2.57M | $33.75M |
| 4 | First Light Asset Management, LLC | 2.46M | $32.35M |
| 5 | Blackrock, Inc. | 2.35M | $30.85M |
| 6 | Orbimed Advisors LLC | 2.10M | $27.57M |
| 7 | Driehaus Capital Management LLC | 1.45M | $19.09M |
| 8 | Deutsche Bank AG\ | 932.1K | $12.26M |
| 9 | Armistice Capital, LLC | 692.0K | $9.10M |
| 10 | Geode Capital Management, LLC | 618.1K | $8.13M |